What's the Difference? Sepracor's Xopenex Hit Hard by Coverage Cut

Xopenex reimbursement is being slashed by Medicare. The message: CMS wants proof of differentiation before it will pay more for line extensions and new formulations. That means trouble ahead for a lot of other products.